Home › Research › Clinical safety
Acetylcholinesterase inhibitors and the risk of delirium – a Danish nationwide register-based cohort study
Martin Torp Rahbek, Helene Kildegaard, Jesper Hallas, Martin Ernst, Lars Christian Lund. Alzheimer s Research & Therapy, 2026-04-28
Topic: Brain proteins, microglia and lab models
Plain-language summary
Among 45,651 patients, 311 delirium events occurred among continuous users and 84 among early discontinuers, corresponding to incidence rates of 66 and 112 events per 10,000 person-years, respectively. The hdPS-weighted HR for delirium was 0.72 (95% CI 0.54–0.96). Results were consistent across sensitivity analyses and in patients with Alzheimer’s disease HR 0.68 (95% CI 0.48–0.96). A negative control outcome showed no association. Continuous AChEI treatment was associated with a lower risk of delirium. Findings support a potential benefit of maintaining therapy in routine dementia care, and possibly even in patients with minor intolerance to acetylcholinesterase inhibitors.
What this study adds
Evidence grade: Low
The record lists 45,651 participants. In this large Danish register study, continuous use of acetylcholinesterase inhibitors was associated with a lower risk of delirium compared with early discontinuation. Reported effect size: HR 0.68 (95% CI 0.48–0.96).
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Rahbek, M. T., Kildegaard, H., Hallas, J., Ernst, M., & Lund, L. C. (2026). Acetylcholinesterase inhibitors and the risk of delirium – a Danish nationwide register-based cohort study. Alzheimer s Research & Therapy. https://doi.org/10.1186/s13195-026-02060-1
Vancouver
Rahbek MT, Kildegaard H, Hallas J, Ernst M, Lund LC. Acetylcholinesterase inhibitors and the risk of delirium – a Danish nationwide register-based cohort study. Alzheimer s Research & Therapy. 2026. doi:10.1186/s13195-026-02060-1. PMID: 42050692.
BibTeX
@article{rahbek2026-42050692,
author = {Rahbek, Martin Torp and Kildegaard, Helene and Hallas, Jesper and Ernst, Martin and Lund, Lars Christian},
title = {{Acetylcholinesterase inhibitors and the risk of delirium – a Danish nationwide register-based cohort study}},
journal = {Alzheimer s Research \& Therapy},
year = {2026},
doi = {10.1186/s13195-026-02060-1},
pmid = {42050692},
url = {https://doi.org/10.1186/s13195-026-02060-1}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Among 45,651 patients, 311 delirium events occurred among continuous users and 84 among early discontinuers, corresponding to incidence rates of 66 and 112 events per 10,000 person-years, respectively.
- The hdPS-weighted HR for delirium was 0.72 (95% CI 0.54–0.96).
- Results were consistent across sensitivity analyses and in patients with Alzheimer’s disease HR 0.68 (95% CI 0.48–0.96).
- A negative control outcome showed no association.
- Continuous AChEI treatment was associated with a lower risk of delirium.
Why it matters
In this large Danish register study, continuous use of acetylcholinesterase inhibitors was associated with a lower risk of delirium compared with early discontinuation. The findings support maintaining this therapy in routine dementia care, though the study design cannot prove that the drugs themselves caused the lower risk.
Study details
- Participants45,651
- Effect sizeHR 0.68 (95% CI 0.48–0.96)
- Evidence strengthLow
How this study scored 44/100
Published in a peer-reviewed journal. Scored zero for study design and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s Research & Therapy) |
| Journal's citation record | 1 / 4 | Alzheimer s Research & Therapy: journal h-index 146 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 4 / 4 | 45,651 participants |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 1 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.5 citations a year over 2 year(s) since 2026 |
| Impact for its field and year | 3 / 6 | Cited 5.6× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 1 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Lars Christian Lund: h-index 21 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | University of Southern Denmark: institution h-index 692 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 42050692) |
| Free to read | 2 / 2 | Free to read |
| Total | 44 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1186/s13195-026-02060-1
- PubMed: 42050692
- Original source →
- Free full text: Alzheimer s Research & Therapy →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Clinical safety from nearby years
Also tagged “trial”
783 studies in the library carry the topic tag “trial”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 783 tagged studies.